Cryopreserved Cord Blood Preparations in Combined Surgical Treatment of Purulent Complications of Type II Diabetes mellitus
Keywords:pyoinflammatory complications of diabetes, metabolic changes, endotoxicosis, preparations of cryopreserved cord blood, correction of homeostasis
Diabetic foot syndrome (DFS) is a serious late complication of Diabetes mellitus (DM) and the unsolved problem of endocrine surgery. This pathology occurs in 80% of patients with diabetes and half of them leads to an extremity amputation. Combined drug and surgical treatment of patients with type II diabetes complications with pyonecrotic DFS stages and sacrococcygeal and perineum phlegmons was analysed. There were used the medical immune biological preparations (MIBP) based on cryopreserved placental blood which contribute to the normalization of immunological reactions, proliferation processes, stimulate a reparation, possess antioxidant, adaptogenic, anti-hypoxic, anabolic and anti-inflammatory effects. The patients were administered with "Cryocell-Cryocord", i.e. placental blood serum (108 patients), and in severe endointoxication they were additionally treated within "Cryocell-Hemocord", placental blood leukoconcentrate (37 patients). When applying MIBP the insulin dosage is reduced by 25-30%. A significant decrease in leukocyte index, the level of an average molecular weight peptides is observed. Cytoarchitecture of erythrocytes significantly improved. Potentiation of the preparations on the activity of metalloenzymes, hepatocyte cytolysis enzymes was found. The number of proteases inhibitors decreases with a parallel increase in the content of albumin, total protein amount, normalization of organ specific enzymes.The increase in total content of immunoglobulins, a sharp decline in the level of circulating immune complexes (antigen-antibody autoantigens) with a parallel increase in the antibodies of natural protection were revealed. In addition, under the influence of cord blood MIBP the wound cleansing and its healing starts faster, pyo-inflammatory process is restricted at the foot level, lower leg edema disappears. The data obtained can be interpreted as recovery of reparative processes in the wound due to effective correction of metabolic-homeostatic changes in the patient suffering from diabetes and its complications.
Probl Cryobiol Cryomed 2014; 24(4):332-345.
Babijchuk L.O., Grischenko V.I., Gurina T.M. et al., inventors. Cryopreservation way for cord blood nucleated cells, including hematopoietic stem cells. Patent of Ukraine N92227, IPC A01N1/02.
Berchun V.V., Bobyriova L.E., Bobyriov V.M., Berchun N.V., inventors. Way for a combined therapy of diabetic foot syndrome. Patent of Ukriane N45675A, IPC A61K 35/50, A61B 17/00, A61P 3/10, A61P 17/02.
Davis W.A., Norman P.E., Bruce D.G., Davis T.M.E. PrÐµdictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: The Fremantle Diabetes Study. Diabetologia 2006; 49: 2634â€“2641. CrossRef PubMed
Fedorenko V.P., Pavlovskiy M.P. Efficiency of Berlithion and Vazoprostan application in a combined surgical treatment of necrotic-inflammatory foot lesions in patients with diabetes mellitus. Surgery of Ukraine 2005; 13(1): 58â€“61.
Goltsev A.N., Kalinichenko T.A. Human umbilical cord blood as a source of hemopoietic cells for clinical application. Part I. Nature of hemopoietic potential. Problems of Cryobiology 1998; (1): 3â€“21.
Goltsev K.A., Ovsyannikov S.Ye., Kozhina O.Yu., Ostankov M.V., Goltsev A.N. Correction of metabolic impairments with 'Cryocell-Hemocord' cord blood preparation during acute purulent peritonitis. Problems of Cryobiology 2011; 21(1): 96â€“103.
Grischenko V.I. Achievements and prospects of cryobiology development in Ukraine. Problems of Cryobiology 2005; 15(3): 231â€“244.
Gryschenko V.I., Lipina O.V., Prokopyuk O.S., Moshko Yu.O., inventors. Biostimulating preparation 'Cryocord-C' and the way for treating salpingoophoritis with its applicaiton. Patent of Ukraine N42454, IPC A61K 35/16, A61P 31/00.
Kaliman V.P. The role of glycosylated hemoglobin and albumin in diagnosis of hyperglycemic states. Experimental and Clinical Medicine 2008; (1): 53â€“55.
Komarov F.I., Korovkin B.F., Menshikov V.V. Biochemical studies in clinic. Elista: APP Dzhangar; 2001.
Meschishin I.F., Pishak V.P., Grigorieva N.P. Basics of metabolism and energy. Chernivtsi: Medical University; 2005.
Ovchinnikova O.V., Bondarenko I.A., Lazurenko V.V. et al. Application of cryopreserved cord blood in treatment of hypoferric anemia in pregnants. Problems of Cryobiology 2008; 18(3): 361â€“363.
Pavlenko I.A., Chepkiy L.P., Ivanyushko O.V., Ilchishin R.O. Endogenic intoxication and its correction under craniocerebral injure. Ukrainian Neurosurgical Journal 2008; (8): 68â€“71.
Popovych Ya.O. Combined surgical treatment of purulent-necrotic lesions in diabetes mellitus with the use of 'Cryocord C'. Klinichna Khirurgiya 2006; (11â€“12): 87.
Shidlovsky V.O., Deikalo I.M., Chepil I.V. Immune-correcting therapy in combined treatment of patients with severe purulent pathologies. Problems of Cryobiology 2005; 15(1): 79â€“84.
Smykodub O.I., Novytska A.V. Therapy of patients with type 2 diabetes mellitus in the disease onset by embryonic stem cells. Transplantologiia 2007; 9(1): 278â€“282.
Tronko N.D. Analysis, priorities, ways of implementation of the State Target Program 'Diabetes Mellitus' during 2009â€“2013. Proceedings of the Ist Congress of Association of Endocrinologists in Ukraine 'New Technologies in Diabetology'; Zdorov'ia Ukrainy 2010; 247(18): 42â€“43.
Turchyn I.S., Larin O.S., Drozdovych I.I. et al. The use of combined organ cultures of endocrine glands for the treatment of endocrinopathy: achievements and prospects. Transplantologiya 2007; 9(1): 293â€“295.
Vasilyuk S.M. Diabetic foot syndrome. Ivano-Frankivsk: DKD; 2005. PubMed
How to Cite
Copyright (c) 2020 Yaroslav O. Popovych
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).